Ignite Creation Date:
2025-12-24 @ 1:20 PM
Ignite Modification Date:
2026-02-01 @ 6:04 AM
Study NCT ID:
NCT00741195
Status:
COMPLETED
Last Update Posted:
2016-10-04
First Post:
2008-08-25
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Docetaxel Plus Bevacizumab in Metastatic Non Small Cell Lung Cancer
Sponsor:
Hellenic Oncology Research Group
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2008-04
Start Date Type:
None
Primary Completion Date:
2016-10
Primary Completion Date Type:
ACTUAL
Completion Date:
2016-10
Completion Date Type:
ACTUAL
First Submit Date:
2008-08-25
First Submit QC Date:
None
Study First Post Date:
2008-08-26
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2016-10-03
Last Update Post Date:
2016-10-04
Last Update Post Date Type:
ESTIMATED